Birmingham City University uses VERT to train students in radiotherapy.


August, 26, 2009 - The Department of Health in the United Kingdom adopted a revolutionary approach to radiotherapy training using Virtual Environment Radiotherapy Training, or VERT, a tool to draw on virtual reality (VR) technology developed by Vertual Ltd.

Now used at 10 universities and dozens of cancer centers all over England, Birmingham City University was a development partner on VERT and one of the first to have the system installed.

VERT allows students to train and experiment in a risk-free, life-like environment, without using actual radiation therapy, even though
students still spend 50 percent of their time shadowing real radiotherapy procedures, workload and capacity pressures in the clinical environment often limit their learning opportunities.
According to Birmingham City University, the VR theater is more useful than originally thought, providing a stereoscopic 3D experience.

Virtual Environment Radiotherapy Training, or VERT, is award winning,
specialist software designed to offer training for radiotherapy students,
nurses and existing staff. It was developed by Prof. Roger Phillips and
James Ward from the University of Hull and Prof. Andy Beavis of the Hull & East Yorkshire Hospitals NHS Trust. Now VERT is being developed and supplied by a spin out company, Vertual Limited. However, for the software to give the level of realism it was designed to provide, it needs a VR stereoscopic 3D visualisation system. Virtalis, Europe’s leading VR company, is Vertual’s supplier of the visualization equipment for VERT. Virtalis installed and provided training for its StereoWorks ActiveWall tracked system at Birmingham City University.

The VERT system can even do things that real life radiotherapy machines can’t. For example, it can visualize how beams of radiation travel within the body and how this affects the distribution of the dose. Our course has now altered to take advantage of VERT, so that we do one week of lectures followed by a week applying what the students have learnt in our VR theatre. Students on clinical placements also attend dedicated simulation weeks here at the University. In fact, students can effectively walk inside their virtual patient.

For more information: www.virtalis.com and www.vertual.co.uk


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
News | Oncology Information Management Systems (OIMS)

May 30, 2024 — RaySearch Laboratories AB announced the release of the latest version of RayCare, the next generation ...

Time May 30, 2024
arrow
Subscribe Now